论文部分内容阅读
目的:对慢性胃炎患者临床治疗中雷贝拉唑加替普瑞酮用药治疗取得的效果分析.方法:收集医院慢性胃炎患46例(2019年1月-2020年1月),以数字1:1形式分组,对照组23例采用替普瑞酮治疗,另外观察组23例在对照组用药基础上加用雷贝拉唑,对两组治疗效果观察.结果:临床治疗有效率观察组95.65％与对照组73.91％组间比较有显著差异(P＜0.05).临床症状如反酸、腹胀与上腹疼痛症状消失时间观察组相比对照组均较少,组间比较有显著差异(P＜0.05).结论:替普瑞酮应用于慢性胃炎患者临床治疗中,联合雷贝拉唑“,”Objective: To analyze the effect of rabeprazole plus tepristone in the treatment of chronic gastritis. Methods :46 cases of chronic gastritis were collected ( January 2019 - January 2020), Grouped in 1 : 1 , In the control group ,23 patients were treated with tepri stone, In addition ,23 cases in the observation group were treated with rabeprazole, The therapeutic effect of the two groups was observed. Results :95. 65％ of the effective rate of clinical treatment was significantly diferent from that of the control group ( P＜0.05 ).Clinical symptoms such as acid regurgita-tion, abdominal distention and the symptoms of upper abdominal pain disappeared in the observationgroup compared with the control group, A sig-nificant difference was found between groups ( P＜0.05). Conclusion: Teprilone is used in the treatment of chronic gastritis, Combined with rabe-prazole, The effect is ideal.